Launching Soon

The MedTech Minute

The $600B medtech industry moves fast. Enterprise publishers move slow. We deliver the essential intel you need in under five minutes, every morning.

$600B+ Global Market
< 5 min Daily Read
100% Signal, Zero Noise

MedTech pros deserve better than 40-page PDFs and paywalled news

The industry is being reshaped by AI, record M&A, and regulatory upheaval. But the media covering it is still built for a slower era. Enterprise publishers, paywalled analysis, and cluttered feeds designed for institutions, not individuals.

Time-starved professionals

Execs, founders, and investors need intel fast. Not 20-minute deep dives before their first meeting.

🔒

Paywalled insights

Premium medtech analysis costs thousands per year. Most individual professionals can't justify the spend.

📶

No personality

Corporate publishers write for committees. Nobody has a real voice. The industry needs a human perspective.

Fast, opinionated medtech intel delivered daily

Built for how you actually consume information

The MedTech Minute distills the most important stories, deals, and regulatory moves into a sharp daily briefing. Read it over coffee. Know what matters. Move on.

  • Top deals, FDA actions, and AI moves curated daily
  • Sharp analysis with a real point of view
  • Sector-specific coverage: robotics, diagnostics, digital health
  • Built in Dallas, covering the global medtech ecosystem
Monday, March 16, 2026
M&A

Boston Scientific's $14.5B Penumbra Bid Reshapes Neuro

The biggest deal of Q1 signals BSX's bet on AI-guided thrombectomy.

FDA

FDA Workforce Cuts Hit Device Review Timelines

510(k) clearances expected to slow 15-20% through mid-2026.

AI

J&J + NVIDIA: AI Enters the Surgical Suite

Monarch robotic platform gets AI simulation for kidney procedures.

FUNDING

Early-Stage MedTech VC Hits $6.4B in H1

AI-native startups capturing disproportionate share of new investment.

Be the first to know what moves medtech

Join the early list. When we launch, you'll be the first to get fast, opinionated intel on the deals, regulation, and tech shaping healthcare.